Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells

被引:314
作者
Cham, Candace M. [1 ,2 ]
Driessens, Gregory [2 ]
O'Keefe, James P. [1 ,2 ]
Gajewski, Thomas F. [1 ,2 ,3 ]
机构
[1] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[3] Univ Chicago, Hematol Oncol Sect, Dept Med, Chicago, IL 60637 USA
关键词
cellular activation; cytotoxicity; gene regulation; T cells;
D O I
10.1002/eji.200838289
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We recently reported that differentiation of CD8(+) T cells from the naive to the effector state involves the upregulation of glucose-dependent metabolism. Glucose deprivation or inhibition of glycolysis by 2-deoxy-D-glucose (2-DG) selectively inhibited production of IFN-gamma but not of IL-2. To determine a more global role of glucose metabolism on effector T-cell function, we performed gene array analysis on CD8(+) effector T cells stimulated in the presence or absence of 2-DG. We observed that expression of only 10% of genes induced by TCR/CD28 signaling was inhibited by 2-DG. Among these were genes for key cytokines, cell cycle molecules, and cytotoxic granule proteins. Consistent with these results, production of IFN-gamma and GM-CSF, cell cycle progression, upregulation of cyclin D2 protein, cytolytic activity, and upregulation of granzyme B protein and also conjugate formation were exquisitely glucose-dependent. In contrast to glucose, oxygen was little utilized by CD8(+) effector T cells, and relative oxygen deprivation did not inhibit these CTL functional properties. Our results indicate a particularly critical role for glucose in regulating specific effector functions of CD8(+) T cells and have implications for the maintenance of the effector phase of cellular immune responses in target tissue microenvironments such as a solid tumor.
引用
收藏
页码:2438 / 2450
页数:13
相关论文
共 33 条
  • [1] Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions
    Caldwell, CC
    Kojima, H
    Lukashev, D
    Armstrong, J
    Farber, M
    Apasov, SG
    Sitkovsky, MV
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (11) : 6140 - 6149
  • [2] Glucose availability regulates IFN-γ production and p70S6 kinase activation in CD8+ effector T cells
    Cham, CM
    Gajewski, TF
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (08) : 4670 - 4677
  • [3] Gene array and protein expression profiles suggest post-transcriptional regulation during CD8+ T cell differentiation
    Cham, CM
    Xu, H
    O'Keefe, JP
    Rivas, FV
    Zagouras, P
    Gajewski, TF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) : 17044 - 17052
  • [4] ACTION OF 5-THIO-D-GLUCOSE AND ITS 1-PHOSPHATE WITH HEXOKINASE AND PHOSPHOGLUCOMUTASE
    CHEN, M
    WHISTLER, RL
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1975, 169 (02) : 392 - 396
  • [5] Fuel feeds function: Energy metabolism and the T-cell response
    Fox, CJ
    Hammerman, PS
    Thompson, CB
    [J]. NATURE REVIEWS IMMUNOLOGY, 2005, 5 (11) : 844 - 852
  • [6] Reactive oxygen species regulate activation-induced T cell apoptosis
    Hildeman, DA
    Mitchell, T
    Teague, TK
    Henson, P
    Day, BJ
    Kappler, J
    Marrack, PC
    [J]. IMMUNITY, 1999, 10 (06) : 735 - 744
  • [7] AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
    Jones, RG
    Plas, DR
    Kubek, S
    Buzzai, M
    Mu, J
    Xu, Y
    Birnbaum, MJ
    Thompson, CB
    [J]. MOLECULAR CELL, 2005, 18 (03) : 283 - 293
  • [8] Molecular and functional profiling of memory CD8 T cell differentiation
    Kaech, SM
    Hemby, S
    Kersh, E
    Ahmed, R
    [J]. CELL, 2002, 111 (06) : 837 - 851
  • [9] The role of oxidative stress in carcinogenesis
    Klaunig, JE
    Kamendulis, LM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 : 239 - 267
  • [10] Defective adhesion in tumor infiltrating CD8+ T cells
    Koneru, Mythili
    Monu, Ngozi
    Schaer, David
    Barletta, Justine
    Frey, Alan B.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (10) : 6103 - 6111